BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31050022)

  • 1. Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole-cell inactivated pneumococcal vaccine.
    David SC; Laan Z; Minhas V; Chen AY; Davies J; Hirst TR; McColl SR; Alsharifi M; Paton JC
    Immunol Cell Biol; 2019 Sep; 97(8):726-739. PubMed ID: 31050022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With
    Jang AY; Ahn KB; Zhi Y; Ji HJ; Zhang J; Han SH; Guo H; Lim S; Song JY; Lim JH; Seo HS
    Front Immunol; 2019; 10():1212. PubMed ID: 31191555
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1.
    Xu X; Meng J; Wang Y; Zheng J; Wu K; Zhang X; Yin Y; Zhang Q
    J Microbiol; 2014 Apr; 52(4):315-23. PubMed ID: 24682994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
    Xu J; Dai W; Wang Z; Chen B; Li Z; Fan X
    Clin Vaccine Immunol; 2011 Jan; 18(1):75-81. PubMed ID: 21047997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
    Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced protective responses to a serotype-independent pneumococcal vaccine when combined with an inactivated influenza vaccine.
    Babb R; Chen A; Ogunniyi AD; Hirst TR; Kara EE; McColl SR; Alsharifi M; Paton JC
    Clin Sci (Lond); 2017 Jan; 131(2):169-180. PubMed ID: 27885052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation.
    Voß F; Kohler TP; Meyer T; Abdullah MR; van Opzeeland FJ; Saleh M; Michalik S; van Selm S; Schmidt F; de Jonge MI; Hammerschmidt S
    Front Immunol; 2018; 9():2405. PubMed ID: 30405609
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
    Chen X; Li B; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Zhang Y; Wu Y
    Med Microbiol Immunol; 2019 Apr; 208(2):215-226. PubMed ID: 30707297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH; Dai WJ; Chen B; Fan XY
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal vaccination with γ-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses.
    Babb R; Chen A; Hirst TR; Kara EE; McColl SR; Ogunniyi AD; Paton JC; Alsharifi M
    Clin Sci (Lond); 2016 May; 130(9):697-710. PubMed ID: 26831937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.
    Wang S; Li Y; Shi H; Scarpellini G; Torres-Escobar A; Roland KL; Curtiss R
    Infect Immun; 2010 Jul; 78(7):3258-71. PubMed ID: 20479086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.
    Yu J; Chen X; Li B; Gu T; Meng X; Kong W; Wu Y
    Immunol Res; 2018 Aug; 66(4):528-536. PubMed ID: 30128745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age.
    Schmid P; Selak S; Keller M; Luhan B; Magyarics Z; Seidel S; Schlick P; Reinisch C; Lingnau K; Nagy E; Grubeck-Loebenstein B
    Vaccine; 2011 May; 29(23):3982-9. PubMed ID: 21481328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
    Arévalo MT; Xu Q; Paton JC; Hollingshead SK; Pichichero ME; Briles DE; Girgis N; Zeng M
    FEMS Immunol Med Microbiol; 2009 Apr; 55(3):346-51. PubMed ID: 19291171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-irradiation of Streptococcus pneumoniae for the use as an immunogenic whole cell vaccine.
    Jwa MY; Jeong S; Ko EB; Kim AR; Kim HY; Kim SK; Seo HS; Yun CH; Han SH
    J Microbiol; 2018 Aug; 56(8):579-585. PubMed ID: 30047087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.
    Moens L; Hermand P; Wellens T; Wuyts G; Derua R; Waelkens E; Ysebaert C; Godfroid F; Bossuyt X
    Hum Vaccin Immunother; 2018 May; 14(5):1234-1242. PubMed ID: 29400602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine.
    Campos IB; Herd M; Moffitt KL; Lu YJ; Darrieux M; Malley R; Leite LC; Gonçalves VM
    Vaccine; 2017 Mar; 35(9):1306-1315. PubMed ID: 28161422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.
    Oliveira ML; Arêas AP; Campos IB; Monedero V; Perez-Martínez G; Miyaji EN; Leite LC; Aires KA; Lee Ho P
    Microbes Infect; 2006 Apr; 8(4):1016-24. PubMed ID: 16549380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.